- Home
- NOMD vs FBIOP Comparison
NOMD vs FBIOP Comparison
Compare NOMD & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOMD
- FBIOP
- Stock Information
- Founded
- NOMD 2014
- FBIOP N/A
- Country
- NOMD United Kingdom
- FBIOP United States
- Employees
- NOMD N/A
- FBIOP 101
- Industry
- NOMD Packaged Foods
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- NOMD Consumer Staples
- FBIOP Health Care
- Exchange
- NOMD Nasdaq
- FBIOP Nasdaq
- Market Cap
- NOMD N/A
- FBIOP N/A
- IPO Year
- NOMD N/A
- FBIOP N/A
- Fundamental
- Price
- NOMD $19.38
- FBIOP $6.70
- Analyst Decision
- NOMD Strong Buy
- FBIOP
- Analyst Count
- NOMD 3
- FBIOP 0
- Target Price
- NOMD $24.00
- FBIOP N/A
- AVG Volume (30 Days)
- NOMD 630.5K
- FBIOP N/A
- Earning Date
- NOMD 05-08-2025
- FBIOP N/A
- Dividend Yield
- NOMD 3.57%
- FBIOP N/A
- EPS Growth
- NOMD 23.92
- FBIOP N/A
- EPS
- NOMD 1.45
- FBIOP N/A
- Revenue
- NOMD $3,209,234,911.00
- FBIOP N/A
- Revenue This Year
- NOMD $3.97
- FBIOP N/A
- Revenue Next Year
- NOMD $2.48
- FBIOP N/A
- P/E Ratio
- NOMD $13.34
- FBIOP N/A
- Revenue Growth
- NOMD 1.82
- FBIOP N/A
- 52 Week Low
- NOMD $15.43
- FBIOP N/A
- 52 Week High
- NOMD $20.81
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- NOMD 50.15
- FBIOP 66.72
- Support Level
- NOMD $19.21
- FBIOP $6.00
- Resistance Level
- NOMD $19.94
- FBIOP $6.80
- Average True Range (ATR)
- NOMD 0.52
- FBIOP 0.41
- MACD
- NOMD 0.00
- FBIOP 0.18
- Stochastic Oscillator
- NOMD 69.71
- FBIOP 90.00
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.